Valerius Biopharma AG develop biosimilar drugs for therapeutic indications with high medical need. The product pipeline consists of four orphan and non-orphan biosimilar drugs that will be developed according to highest regulatory standards to enable global access for patients at affordable prices.
Valerius Biopharma AG
Verified listing
-
Founded2017
-
Employees in Switzerland1-9
- Get directions
- Bookmark
- Share
- Report
- prev
- next